Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
Efalizumab - anti CD11a recombinant human monoclonal antibody (mAb)
/
mega-study
Efalizumab - anti CD11a recombinant human monoclonal antibody (mAb)